BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24631771)

  • 1. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
    Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
    J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
    Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
    Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.
    Kehat I; Davis J; Tiburcy M; Accornero F; Saba-El-Leil MK; Maillet M; York AJ; Lorenz JN; Zimmermann WH; Meloche S; Molkentin JD
    Circ Res; 2011 Jan; 108(2):176-83. PubMed ID: 21127295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.
    Ruppert C; Deiss K; Herrmann S; Vidal M; Oezkur M; Gorski A; Weidemann F; Lohse MJ; Lorenz K
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7440-5. PubMed ID: 23589880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
    Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
    J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
    Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
    ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
    Ma Q; Liu Y; Chen L
    Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
    Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
    Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
    Purcell NH; Wilkins BJ; York A; Saba-El-Leil MK; Meloche S; Robbins J; Molkentin JD
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14074-9. PubMed ID: 17709754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p42/p44 mitogen-activated protein kinases inhibit atrial natriuretic peptide mRNA transcription in gp130-mediated hypertrophic ventricular myocytes.
    Dong ZL; Wang Y; Li TF; Zheng SJ; Kong YQ; Lan YL; Guo JL; Fu SG
    Asian Pac J Trop Med; 2014 Mar; 7(3):216-20. PubMed ID: 24507643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
    Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
    Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol-Induced Suppression of the MiR-21/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction.
    Cheng M; Wu G; Song Y; Wang L; Tu L; Zhang L; Zhang C
    Cell Physiol Biochem; 2016; 38(5):1928-38. PubMed ID: 27160852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy.
    Kehat I; Molkentin JD
    Ann N Y Acad Sci; 2010 Feb; 1188():96-102. PubMed ID: 20201891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
    Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
    Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.